Patent Application
App. No. 13/077,028
NEO-TRYPTOPHAN
Loading inventors, assignments & file history…
Abstract
Methods of inducing antinociception in a human are described. The method includes the step of administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. The polypeptide containing L-neo-tryptophan could be, but is not limited to, NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, or NT77.
Claims (2)
1 . A method of inducing antinociception in a human, said method comprising administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially.
2 . The method of claim 1 , wherein the polypeptide is selected from the group consisting of NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, and NT77.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 24, 2011
From: RICHELSON, ELLIOTT; CUSACK, BERNADETTE MARIE; PANG, YUAN PING; MCCORMICK, DANIEL J.; FAUQ, ABDUL; TYLER, BETH MARIE; BOULES, MONA
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 026331/0113 →
CONFIRMATORY LICENSE
Recorded Apr 20, 2011
From: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026152/0940 →